Analystreport

Catabasis Pharmaceuticals, Inc. (NASDAQ: CATB) is now covered by analysts at Wedbush. They set an "outperform" rating and a $16.00 price target on the stock.

Catabasis Pharmaceuticals, Inc.  (CATB) 
Last catabasis pharmaceuticals, inc. earnings: 3/10 08:05 am Check Earnings Report
US:NASDAQ Investor Relations: ir.catabasis.com/investor-overview